RIGL
Rigel Pharmaceuticals Inc
NASDAQ: RIGL · HEALTHCARE · BIOTECHNOLOGY
$29.22
-4.38% today
Updated 2026-04-29
Market cap
$564.75M
P/E ratio
1.57
P/S ratio
1.92x
EPS (TTM)
$19.48
Dividend yield
—
52W range
$17 – $52
Volume
0.4M
Rigel Pharmaceuticals Inc (RIGL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |